Louisiana Man Gets First Gene Therapy for Hemophilia A

Jacob Beard walked into a Metairie clinic needing regular infusions to prevent spontaneous bleeding, and he walked out with the potential for a completely different life.

The 26-year-old became the first person in Louisiana to receive gene therapy for severe hemophilia A at the Louisiana Center for Bleeding and Clotting Disorders in December. Until now, people with this blood disorder required frequent intravenous treatments of clotting factor to prevent dangerous bleeding episodes.

Gene therapy works by delivering a functional copy of the missing gene directly into the body's cells. Once inside, those cells can finally produce the clotting protein that people with hemophilia A lack naturally, potentially eliminating the need for regular treatments.

The Louisiana Center for Bleeding and Clotting Disorders, located within Tulane University School of Medicine, operates clinics across the state in New Orleans, Metairie, Lafayette, and Alexandria. The center also successfully administered Louisiana's first gene therapy for hemophilia B in 2025, marking a banner year for blood disorder treatment in the state.

The Ripple Effect

This breakthrough extends far beyond one patient. Louisiana joins a growing network of states offering gene therapy for hemophilia, bringing cutting-edge treatment closer to home for families who previously would have traveled out of state.

The center's expansion of gene therapy services means more Louisiana residents with bleeding disorders can access potentially life-changing treatments without leaving their communities. For young patients especially, the difference between a lifetime of regular infusions and the possibility of producing their own clotting factor represents a fundamental shift in quality of life.

Meanwhile, other Louisiana medical institutions are advancing healthcare on multiple fronts. Ochsner is participating in a national study testing the Galleri multi-cancer early detection test, which analyzes DNA patterns in blood to catch cancer signals before symptoms appear.

Franciscan Missionaries of Our Lady University just completed a $2 million renovation of its School of Health Professions Building, adding advanced laboratories and a rehabilitation gym. LSU Health New Orleans received a $20,000 grant as one of only six teams nationwide studying stimulant use disorders.

Louisiana's medical landscape is quietly transforming, one breakthrough at a time.